Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

BACKGROUND: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users (e.g., simvastatin), motivating calls for clinica...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Acta Oncol
Main Authors:	Ahern, Thomas P., Damkier, Per, Feddersen, Søren, Kjærsgaard, Anders, Lash, Timothy L., Hamilton-Dutoit, Stephen, Lythjohan, Cathrine Bredal, Ejlertsen, Bent, Christiansen, Peer M., Cronin-Fenton, Deirdre P.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2020
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7483991/ https://ncbi.nlm.nih.gov/pubmed/32351149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2020.1759820
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

Lignende værker